Abstract

Data from the Strategic Reperfusion Early After Myocardial Infarction (STREAM) trial6 and 5-year results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI)7 are evaluated for further evidence on the effectiveness and safety of a pharmacoinvasive approach for patients presenting with acute ST-segment elevation myocardial infarction (STEMI).

Highlights

  • Primary percutaneous coronary intervention (PPCI) is currently the preferred reperfusion therapy for patients presenting with acute ST-segment elevation myocardial infarction (STEMI) when it can be performed by an experienced team in a timely fashion.[1]

  • When this is not feasible, as is the case in many areas around the world, a pharmacoinvasive strategy consisting of early fibrinolysis followed by transfer to a PCI-capable hospital for either immediate PCI for patients with failed thrombolysis, or for non-urgent coronary angiography to determine the need for additional revascularization within 3 – 24 is a reasonable alternative.[2,3]

  • In agreement with several recent studies[10,11,12,13] as well as the current American and European practice guidelines,[2,3] both Strategic Reperfusion Early After Myocardial Infarction (STREAM) and FAST-MI support the current recommendation of performing a coronary angiogram within 3 –24 hours after successful fibrinolysis when timely PPCI is unavailable

Read more

Summary

Introduction

Primary percutaneous coronary intervention (PPCI) is currently the preferred reperfusion therapy for patients presenting with acute ST-segment elevation myocardial infarction (STEMI) when it can be performed by an experienced team in a timely fashion.[1]. INTRODUCTION Primary percutaneous coronary intervention (PPCI) is currently the preferred reperfusion therapy for patients presenting with acute ST-segment elevation myocardial infarction (STEMI) when it can be performed by an experienced team in a timely fashion.[1] Current practice guidelines recommend the transfer of patients presenting to non-PCI capable hospitals to hospitals offering PPCI services if the first medical contact (FMC)-to-device time is kept to less than 120 minutes.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.